JP2018518957A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518957A5 JP2018518957A5 JP2017565149A JP2017565149A JP2018518957A5 JP 2018518957 A5 JP2018518957 A5 JP 2018518957A5 JP 2017565149 A JP2017565149 A JP 2017565149A JP 2017565149 A JP2017565149 A JP 2017565149A JP 2018518957 A5 JP2018518957 A5 JP 2018518957A5
- Authority
- JP
- Japan
- Prior art keywords
- host cell
- seq
- nucleotide sequence
- identity
- expression construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 claims description 101
- 125000003729 nucleotide group Chemical group 0.000 claims description 101
- 108090000623 proteins and genes Proteins 0.000 claims description 95
- 210000004027 cell Anatomy 0.000 claims description 69
- 230000001939 inductive effect Effects 0.000 claims description 64
- 239000000411 inducer Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 108091033319 polynucleotide Proteins 0.000 claims description 16
- 239000002157 polynucleotide Substances 0.000 claims description 16
- 102000040430 polynucleotide Human genes 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 11
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical group CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 9
- 101150076178 araE gene Proteins 0.000 claims description 8
- 101150085802 prpB gene Proteins 0.000 claims description 7
- 102000014914 Carrier Proteins Human genes 0.000 claims description 6
- 108010078791 Carrier Proteins Proteins 0.000 claims description 6
- 101100532764 Escherichia coli (strain K12) scpC gene Proteins 0.000 claims description 6
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 6
- 101100345719 Bacillus subtilis (strain 168) mmgE gene Proteins 0.000 claims description 5
- 101100345721 Bacillus subtilis (strain 168) mmgF gene Proteins 0.000 claims description 5
- 125000003599 L-arabinosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)CO1)* 0.000 claims description 5
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 claims description 5
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 claims description 5
- 101150035354 araA gene Proteins 0.000 claims description 5
- 101150079081 pphB gene Proteins 0.000 claims description 5
- 101150077061 prpD gene Proteins 0.000 claims description 5
- 101150057627 trxB gene Proteins 0.000 claims description 5
- 230000002103 transcriptional effect Effects 0.000 claims description 4
- NYHBQMYGNKIUIF-FJFJXFQQSA-N 9-beta-D-arabinofuranosylguanine Chemical compound C12=NC(N)=NC(O)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O NYHBQMYGNKIUIF-FJFJXFQQSA-N 0.000 claims description 3
- 101150019464 ARAF gene Proteins 0.000 claims description 3
- HMFHBZSHGGEWLO-IOVATXLUSA-N D-xylofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-IOVATXLUSA-N 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 101100002294 Escherichia coli (strain K12) argK gene Proteins 0.000 claims description 3
- 101100416564 Escherichia coli (strain K12) rfbA gene Proteins 0.000 claims description 3
- 101100095178 Escherichia coli (strain K12) scpB gene Proteins 0.000 claims description 3
- 101150088541 SCPA gene Proteins 0.000 claims description 3
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 claims description 3
- 101150097746 araB gene Proteins 0.000 claims description 3
- 101150084021 araG gene Proteins 0.000 claims description 3
- 101150023525 araH gene Proteins 0.000 claims description 3
- 101150092394 argK gene Proteins 0.000 claims description 3
- 108010066381 preproinsulin Proteins 0.000 claims description 3
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 101150055510 rfbB gene Proteins 0.000 claims description 3
- 101150117748 rfbC gene Proteins 0.000 claims description 3
- 101150061409 rfbD gene Proteins 0.000 claims description 3
- 101150091078 rhaA gene Proteins 0.000 claims description 3
- 101150032455 rhaB gene Proteins 0.000 claims description 3
- 101150052254 rhaD gene Proteins 0.000 claims description 3
- 101150097837 rhaT gene Proteins 0.000 claims description 3
- 101150099889 rmlA gene Proteins 0.000 claims description 3
- 101150043440 rmlB gene Proteins 0.000 claims description 3
- 101150016581 rmlC gene Proteins 0.000 claims description 3
- 101150078780 rmlD gene Proteins 0.000 claims description 3
- 101150024466 scpB gene Proteins 0.000 claims description 3
- 101150033155 sspP gene Proteins 0.000 claims description 3
- 101150011516 xlnD gene Proteins 0.000 claims description 3
- 101150052264 xylA gene Proteins 0.000 claims description 3
- 101150110790 xylB gene Proteins 0.000 claims description 3
- 101150010108 xylF gene Proteins 0.000 claims description 3
- 101150068654 xylG gene Proteins 0.000 claims description 3
- 101150004248 xylH gene Proteins 0.000 claims description 3
- 101100429087 Bacillus subtilis (strain 168) xlyA gene Proteins 0.000 claims description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 101150009573 phoA gene Proteins 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 5
- 108010036164 Glutathione synthase Proteins 0.000 description 4
- 101100015982 Dictyostelium discoideum gcsA gene Proteins 0.000 description 2
- 101100172084 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) egtA gene Proteins 0.000 description 2
- 101100369961 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) erv-1 gene Proteins 0.000 description 2
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 101150019860 gshA gene Proteins 0.000 description 2
- 101150096947 gshB gene Proteins 0.000 description 2
- 108020003519 protein disulfide isomerase Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021106797A JP2021153600A (ja) | 2015-06-16 | 2021-06-28 | 誘導性共発現系における使用のためのベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/740,475 | 2015-06-16 | ||
| US14/740,475 US20150353940A1 (en) | 2013-08-05 | 2015-06-16 | Vectors for use in an inducible coexpression system |
| PCT/US2016/037942 WO2016205570A1 (en) | 2015-06-16 | 2016-06-16 | Vectors for use in an inducible coexpression system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021106797A Division JP2021153600A (ja) | 2015-06-16 | 2021-06-28 | 誘導性共発現系における使用のためのベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518957A JP2018518957A (ja) | 2018-07-19 |
| JP2018518957A5 true JP2018518957A5 (enExample) | 2019-07-25 |
| JP6976860B2 JP6976860B2 (ja) | 2021-12-08 |
Family
ID=54769087
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017565149A Active JP6976860B2 (ja) | 2015-06-16 | 2016-06-16 | 誘導性共発現系における使用のためのベクター |
| JP2021106797A Pending JP2021153600A (ja) | 2015-06-16 | 2021-06-28 | 誘導性共発現系における使用のためのベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021106797A Pending JP2021153600A (ja) | 2015-06-16 | 2021-06-28 | 誘導性共発現系における使用のためのベクター |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20150353940A1 (enExample) |
| EP (2) | EP4039810A1 (enExample) |
| JP (2) | JP6976860B2 (enExample) |
| KR (1) | KR102716963B1 (enExample) |
| CN (1) | CN107849572A (enExample) |
| AU (2) | AU2016278242B2 (enExample) |
| CA (1) | CA2986443A1 (enExample) |
| DK (1) | DK3310919T3 (enExample) |
| ES (1) | ES2906725T3 (enExample) |
| IL (2) | IL307555A (enExample) |
| MX (1) | MX390195B (enExample) |
| WO (1) | WO2016205570A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017106583A1 (en) * | 2015-12-15 | 2017-06-22 | Absci, Llc | Cytoplasmic expression system |
| US12157766B2 (en) | 2012-08-05 | 2024-12-03 | Absci Corporation | Cytoplasmic expression system |
| CA3114395A1 (en) | 2018-09-25 | 2020-04-02 | Absci, Llc | Protein purification methods |
| KR20210090645A (ko) | 2018-11-05 | 2021-07-20 | 제넨테크, 인크. | 원핵 숙주 세포에서 2개의 사슬 단백질을 생산하는 방법 |
| CN111269294B (zh) * | 2018-12-05 | 2023-03-28 | 广州中国科学院先进技术研究所 | 纤维寡糖转运蛋白LacY的突变位点、突变转运蛋白LacY及其制备方法和应用 |
| CN111979206B (zh) * | 2019-05-24 | 2021-08-17 | 深圳瑞德林生物技术有限公司 | 固定化融合酶及用其制备谷胱甘肽的方法 |
| AU2021312935B2 (en) * | 2020-07-24 | 2024-11-28 | Duke University | Methods and compositions for the production of acetyl-CoA derived products |
| US20220380783A1 (en) * | 2021-05-06 | 2022-12-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and system of managing resource competition in synthetic gene circuits |
| CN113528410A (zh) * | 2021-06-23 | 2021-10-22 | 云舟生物科技（广州）有限公司 | 一种用于快速高效诱导表达外源蛋白的大肠杆菌工程菌及其制备方法与应用 |
| WO2023114905A1 (en) | 2021-12-16 | 2023-06-22 | Absci Corporation | Membrane-associated fusion proteins to increase the competency of cells |
| IL313521A (en) | 2021-12-17 | 2024-08-01 | Absci Corp | Solid-phase screening for high-throughput bacterial strains |
| CN118510902A (zh) | 2021-12-21 | 2024-08-16 | Absci公司 | 用于鉴定具有增加的可溶性靶蛋白表达的菌株的FolA选择测定 |
| EP4453198A1 (en) | 2021-12-23 | 2024-10-30 | ABSCI Corporation | Products and methods for heterologous expression of proteins in a host cell |
| WO2023129881A1 (en) * | 2021-12-30 | 2023-07-06 | Absci Corporation | Knockout of ptsp gene elevates active gene expression |
| US20230268026A1 (en) | 2022-01-07 | 2023-08-24 | Absci Corporation | Designing biomolecule sequence variants with pre-specified attributes |
| WO2024006269A1 (en) | 2022-06-29 | 2024-01-04 | Absci Corporation | Affinity screening method |
| WO2024040020A1 (en) | 2022-08-15 | 2024-02-22 | Absci Corporation | Quantitative affinity activity specific cell enrichment |
| WO2024254237A1 (en) | 2023-06-08 | 2024-12-12 | Absci Corporation | Solid-phase screening for high-performing bacterial strains |
| WO2025058962A1 (en) | 2023-09-11 | 2025-03-20 | Absci Corporation | High-throughput methods for kinetic characterization, quantifying and optimizing antibodies and antibody fragments expression in bacteria |
| WO2025076081A1 (en) | 2023-10-03 | 2025-04-10 | Absci Corporation | Tl1a associated antibody compositions and methods of use |
| WO2025122885A1 (en) | 2023-12-08 | 2025-06-12 | Absci Corporation | Anti-her2 associated antibody compositions designed by artificial intelligence and methods of use |
| WO2025144700A1 (en) | 2023-12-27 | 2025-07-03 | Absci Corporation | Nanobody library screening using bacterial surface display |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3344618B2 (ja) | 1997-06-20 | 2002-11-11 | 株式会社エイチ・エス・ピー研究所 | シャペロン発現プラスミド |
| ATE449844T1 (de) * | 1997-12-05 | 2009-12-15 | Europ Lab Molekularbiolog | Neue methode zur klonierung dns unter anwendung des e. coli rece/rect rekombinationssystems |
| US6780405B1 (en) | 2000-04-28 | 2004-08-24 | Avant Immunotherapeutics, Inc. | Regulated antigen delivery system (RADS) |
| US6979556B2 (en) * | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
| DE60135498D1 (de) * | 2000-12-14 | 2008-10-02 | Genentech Inc | Produktion von ganzen Antikörpern in prokaryontischen Zellen |
| JP4461210B2 (ja) * | 2001-08-27 | 2010-05-12 | ジェネンテック， インコーポレイテッド | 抗体発現系とその構築法 |
| WO2005040388A2 (en) * | 2003-08-22 | 2005-05-06 | Nucleonics Inc. | Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
| US8227241B2 (en) * | 2004-03-12 | 2012-07-24 | Unigene Laboratories, Inc. | Bacterial host cell for the direct expression of peptides |
| DE102004061846A1 (de) * | 2004-12-22 | 2006-07-13 | Basf Ag | Mehrfachpromotoren |
| CA2610405C (en) | 2005-06-06 | 2015-01-27 | Dow Global Technologies Inc. | Mannitol induced promoter systems in bacterial host cells |
| US8178338B2 (en) | 2005-07-01 | 2012-05-15 | The Regents Of The University Of California | Inducible expression vectors and methods of use thereof |
| EP2155789B1 (en) | 2007-05-01 | 2013-07-24 | Research Development Foundation | Immunoglobulin fc libraries |
| US8999668B2 (en) | 2008-01-03 | 2015-04-07 | Cornell Research Foundation, Inc. | Glycosylated protein expression in prokaryotes |
| KR100958096B1 (ko) * | 2008-02-11 | 2010-05-14 | 한국과학기술원 | 염색체 특정 부위 제거용 재조합 벡터 및 이를 이용한미생물 내 염색체 특정 부위의 제거방법 |
| DK2379722T3 (da) * | 2008-12-16 | 2017-01-02 | C-Lecta Gmbh | Ekspressionsvektor |
| CA2754928A1 (en) * | 2009-03-10 | 2010-09-16 | Athena Biotechnologies, Inc. | Reducing carbon dioxide production and increasing ethanol yield during microbial ethanol fermentation |
| US8623652B2 (en) * | 2009-04-06 | 2014-01-07 | Lucigen Corporation | Host-vector system for cloning and expressing genes |
| AU2010322454B2 (en) * | 2009-11-19 | 2016-05-19 | Glaxosmithkline Biologicals S.A. | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| US8603797B2 (en) * | 2010-03-17 | 2013-12-10 | Cornell University | Methods and compositions for targeted mutagenesis in bacteria |
| EP2386641A1 (en) | 2010-05-11 | 2011-11-16 | Université Catholique De Louvain | Method for extracellular production of recombinant biomolecules in a microorganism |
| DK2880168T3 (en) * | 2012-08-05 | 2017-04-18 | Absci Llc | INDUCERABLE CO EXPRESSION SYSTEM |
| EP3030651A4 (en) * | 2013-08-05 | 2017-02-22 | Aronora, Inc. | Coordinated coexpression of thrombin |
-
2015
- 2015-06-16 US US14/740,475 patent/US20150353940A1/en not_active Abandoned
-
2016
- 2016-06-16 WO PCT/US2016/037942 patent/WO2016205570A1/en not_active Ceased
- 2016-06-16 JP JP2017565149A patent/JP6976860B2/ja active Active
- 2016-06-16 IL IL307555A patent/IL307555A/en unknown
- 2016-06-16 KR KR1020187000942A patent/KR102716963B1/ko active Active
- 2016-06-16 IL IL256094A patent/IL256094B2/en unknown
- 2016-06-16 CA CA2986443A patent/CA2986443A1/en active Pending
- 2016-06-16 ES ES16812476T patent/ES2906725T3/es active Active
- 2016-06-16 CN CN201680035423.4A patent/CN107849572A/zh active Pending
- 2016-06-16 EP EP21214179.0A patent/EP4039810A1/en active Pending
- 2016-06-16 AU AU2016278242A patent/AU2016278242B2/en active Active
- 2016-06-16 MX MX2017016400A patent/MX390195B/es unknown
- 2016-06-16 EP EP16812476.6A patent/EP3310919B1/en active Active
- 2016-06-16 DK DK16812476.6T patent/DK3310919T3/da active
- 2016-09-11 US US15/261,984 patent/US11371048B2/en active Active
-
2021
- 2021-06-28 JP JP2021106797A patent/JP2021153600A/ja active Pending
-
2022
- 2022-09-08 AU AU2022228166A patent/AU2022228166A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018518957A5 (enExample) | ||
| AU2012264606B2 (en) | Transcription terminator sequences | |
| Xiao et al. | Engineering cells to improve protein expression | |
| JP2015524281A5 (enExample) | ||
| EP2862933B1 (en) | Bidirectional promoter | |
| WO2018031950A1 (en) | Protein engineering methods | |
| CN103898140B (zh) | 一种简便高效的基因编辑方法 | |
| KR20180132705A (ko) | 단백질 생산 및 라이브러리(Library) 생성을 위한 포유동물 세포주 | |
| US8999673B2 (en) | Method for specifically producing a joined DNA fragment comprising a sequence derived from a target gene | |
| KR20250006998A (ko) | Crispr 이용의 다중화된 게놈 조작 | |
| CN104884467A (zh) | 在遗传修饰的哺乳动物细胞中生产治疗性蛋白质 | |
| JP2020509763A5 (enExample) | ||
| WO2019128837A1 (zh) | 一种改进的启动子及其组成的载体和应用 | |
| Feary et al. | CHOK1SV GS‐KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection | |
| CN107142247B (zh) | 可诱导的CRISPRon或CRISPRi小鼠胚胎干细胞及其应用 | |
| Vopálenský et al. | Messenger RNAs of yeast virus-like elements contain non-templated 5′ Poly (A) leaders, and their expression is independent of eIF4E and Pab1 | |
| JP7026304B2 (ja) | 部位特異的ｄｎａ開裂及び修復による標的化原位置タンパク質多様化 | |
| KR20230134409A (ko) | 관심 rna 및/또는 유용물질의 생산을 위한 세포, 전사-번역을 하는 시스템 및 rna 전사시스템, 그리고 이들의 방법 및 생산물 | |
| Kopsidas et al. | RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution | |
| KR101765255B1 (ko) | rnpA 유전자 발현감소를 통한 재조합단백질의 제조방법 | |
| ES2849728T3 (es) | Selectividad eficiente de proteínas recombinantes | |
| JP5246904B2 (ja) | 外来遺伝子導入用ベクター及び外来遺伝子が導入されたベクターの製造方法 | |
| EP3159411A1 (en) | Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof | |
| KR20250131769A (ko) | 절단된 격리자 및 이의 응용 | |
| KR20230134413A (ko) | 관심 rna 및/또는 유용물질의 생산을 위한 세포, 무세포 시스템 및 rna 전사시스템, 그리고 이들의 방법 및 생산물 |